This Article  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Social Bookmarking   What's this?

JAMA. 2002;287:921-922.

Physicians in the United States, Canada, and Mexico
Physicians with current and valid licenses in the United States, Canada, or Mexico who read any 3 of the selected continuing medical education (CME) articles in this issue of JAMA, complete the CME Evaluation Form, and fax it to the number or mail it to the address at the bottom of the CME Evaluation Form are eligible for category 1 CME credit. There is no charge.

The American Medical Association (AMA) is accredited by the Accreditation Council for Continuing Medical Education to sponsor CME for physicians. The AMA designates this educational activity for up to 1 hour of category 1 CME credit per JAMA issue toward the AMA Physician's Recognition Award (PRA). Each physician should claim for credit only those hours that were actually spent in this educational activity.

Physicians in Other Countries
Physicians with current and valid licenses in the United States, Mexico, or Canada are eligible for CME credit even if they live or practice in other countries. Physicians licensed in other countries are also welcome to participate in this CME activity. However, the PRA is available only to physicians licensed in the United States, Canada, or Mexico.

Earning Credit and the CME Evaluation Form
To earn credit, read 3 of the articles listed below that are designated for CME credit carefully and complete the CME Evaluation Form. The CME Evaluation Form must be submitted within 1 month of the issue date. A certificate awarding 1 hour of category 1 CME credit will be faxed or mailed to you; it is then your responsibility to maintain a record of credit received.

One of our goals is to assess continually the educational needs of our readers so we may enhance the educational effectiveness of JAMA. To achieve this goal, we need your help. You must complete the CME Evaluation Form to receive credit.

Statement of Educational Purpose
JAMA is a general medical journal. Its mission and educational purpose is to promote the science and art of medicine and the betterment of the public health. A flexible curriculum of article topics is developed annually by THE JOURNAL's editorial board and is then supplemented throughout the year with information gained from readers, authors, reviewers, and editors. To accommodate the diversity of practice types within JAMA's readership, the Reader's Choice CME activity allows readers, as adult learners, to determine their own educational needs and to assist the editors in addressing their needs in future issues.

Readers of JAMA should be able to attain the following educational objectives: (1) select and read at least 3 articles in 1 issue to gain new medical information on topics of particular interest to them as physicians, (2) assess the articles' value to them as practicing physicians, and (3) think carefully about how this new information may influence their own practices. The educational objective for each CME article is given after the article title below.

CME Articles in This Issue of JAMA
The following articles in this issue may be read for CME credit:

Raloxifene and Cardiovascular Events in Osteoporotic Postmenopausal Women: Four-Year Results From the MORE (Multiple Outcomes of Raloxifene Evaluation) Randomized Trial (SEE ARTICLE)

Educational Objective: To learn that a selective estrogen receptor modulator may reduce the risk of cardiovascular events for women at increased cardiovascular risk.

Fatal Inhalational Anthrax With Unknown Source of Exposure in a 61-Year-Old Woman in New York City (SEE ARTICLE)

Educational Objective: To learn about a case of inhalational anthrax without a known source of exposure.

Fatal Inhalational Anthrax in a 94-Year-Old Connecticut Woman (SEE ARTICLE)

Educational Objective: To learn about the clinical features and diagnostic difficulties of a case of inhalational anthrax.

Cutaneous Anthrax Associated With Microangiopathic Hemolytic Anemia and Coagulopathy in a 7-Month-Old Infant (SEE ARTICLE)

Educational Objective: To compare the clinical manifestations of cutaneous anthrax and spider toxin disease.

Secondary and Tertiary Palliative Care in US Hospitals (SEE ARTICLE)

Educational Objective: To understand the use of palliative care services in hospitals and health systems.

-Blocker Therapy in Heart Failure: Scientific Review (SEE ARTICLE)

Educational Objective: To review the use of -blocker drugs for heart failure.

-Blockers in Heart Failure: Clinical Applications (SEE ARTICLE)

Educational Objective: To understand which patients with heart failure may benefit most from -blocker therapy.

After reading 3 of these articles, complete the CME Evaluation Form.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Raloxifene and Cardiovascular Events in Osteoporotic Postmenopausal Women: Four-Year Results From the MORE (Multiple Outcomes of Raloxifene Evaluation) Randomized Trial
Elizabeth Barrett-Connor, Deborah Grady, Andreas Sashegyi, Pamela W. Anderson, David A. Cox, Krzysztof Hoszowski, Pentti Rautaharju, Kristine D. Harper, and for the MORE Investigators
JAMA. 2002;287(7):847-857.
ABSTRACT | FULL TEXT  

Fatal Inhalational Anthrax With Unknown Source of Exposure in a 61-Year-Old Woman in New York City
Bushra Mina, J. P. Dym, Frank Kuepper, Raymond Tso, Carmina Arrastia, Irina Kaplounova, Hasan Faraj, Agnieszka Kwapniewski, Christopher M. Krol, Mayer Grosser, Jeffrey Glick, Steven Fochios, Athena Remolina, Ljiljana Vasovic, Jeffrey Moses, Thomas Robin, Maria DeVita, and Michael L. Tapper
JAMA. 2002;287(7):858-862.
ABSTRACT | FULL TEXT  

Fatal Inhalational Anthrax in a 94-Year-Old Connecticut Woman
Lydia A. Barakat, Howard L. Quentzel, John A. Jernigan, David L. Kirschke, Kevin Griffith, Stephen M. Spear, Katherine Kelley, Diane Barden, Donald Mayo, David S. Stephens, Tanja Popovic, Chung Marston, Sherif R. Zaki, Jeanette Guarner, Wun-Ju Shieh, H. Wayne Carver II, Richard F. Meyer, David L. Swerdlow, Eric E. Mast, James L. Hadler, and for the Anthrax Bioterrorism Investigation Team
JAMA. 2002;287(7):863-868.
ABSTRACT | FULL TEXT  

Cutaneous Anthrax Associated With Microangiopathic Hemolytic Anemia and Coagulopathy in a 7-Month-Old Infant
Abigail Freedman, Olubunmi Afonja, Mary Wu Chang, Farzad Mostashari, Martin Blaser, Guillermo Perez-Perez, Herb Lazarus, Robert Schacht, Jane Guttenberg, Michael Traister, and William Borkowsky
JAMA. 2002;287(7):869-874.
ABSTRACT | FULL TEXT  

Secondary and Tertiary Palliative Care in US Hospitals
Charles F. von Gunten
JAMA. 2002;287(7):875-881.
ABSTRACT | FULL TEXT  

-Blocker Therapy in Heart Failure: Scientific Review
JoAnne Micale Foody, Michael H. Farrell, and Harlan M. Krumholz
JAMA. 2002;287(7):883-889.
ABSTRACT | FULL TEXT  

-Blockers in Heart Failure: Clinical Applications
Michael H. Farrell, JoAnne Micale Foody, and Harlan M. Krumholz
JAMA. 2002;287(7):890-897.
ABSTRACT | FULL TEXT